EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overview of growth differentiation factor 15 in metabolic syndrome

Mohamed Asrih, Shibo Wei, Thanh T Nguyen, Hyon-Seung Yi, Dongryeol Ryu iD, Karim Gariani iD

Journal of Cellular and Molecular Medicine · 2023-05 · 27 (9) · 1157-1167

DOI: 10.1111/jcmm.17725 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 29.03.2023. Verfasst von Mohamed Asrih und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetology, Nutrition and Therapeutic Patient Education, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Metabolic Syndrome. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth and differentiation factor 15 (GDF15) is a member of the transforming growth factor‐β (TGF‐β) superfamily. GDF15 has been linked with several metabolic syndrome pathologies such as obesity and cardiovascular diseases. GDF15 is considered to be a metabolic regulator, although its precise mechanisms of action remain to be determined. Glial cell‐derived neurotrophic factor family receptor alpha‐like (GRAL), located in the hindbrain, has been identified as the receptor for GDF15 and signals through the coreceptor receptor tyrosine kinase (RET). Administration of GDF15 analogues in preclinical studies using various animal models has consistently been shown to induce weight loss through a reduction in food intake. GDF15, therefore, represents an attractive target to combat the current global obesity epidemic. In this article, we review current knowledge on GDF15 and its involvement in metabolic syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeAnimalsGrowth Differentiation Factor 15Glial Cell Line-Derived Neurotrophic Factor ReceptorsObesityWeight Loss

Stichwörter der Autor:innen

growth differentiation factor 15inflammatory statemetabolic syndromeobesity

Substanzen

Growth Differentiation Factor 15Glial Cell Line-Derived Neurotrophic Factor Receptors

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetology, Nutrition and Therapeutic Patient Education, Geneva University Hospitals, Geneva, Switzerland.
  • Diabetes Center of the Faculty of Medicine, University of Geneva Medical School, Geneva, Switzerland.
  • Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea.
  • Department of Biophysics, Institute of Quantum Biophysics, Sungkyunkwan University (SKKU), Suwon, Korea.
  • Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea.
  • Laboratory of Endocrinology and Immune System, Chungnam National University School of Medicine, Daejeon, South Korea.

ORCID-Profile: Dongryeol Ryu, Karim Gariani

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Asrih, M., Wei, S., Nguyen, T. T., Yi, H. S., Ryu, D., & Gariani, K. (2023). Overview of growth differentiation factor 15 in metabolic syndrome. Journal of Cellular and Molecular Medicine, 27(9), 1157-1167. https://doi.org/10.1111/jcmm.17725

Vancouver

Asrih M, Wei S, Nguyen TT, Yi HS, Ryu D, Gariani K. Overview of growth differentiation factor 15 in metabolic syndrome. Journal of Cellular and Molecular Medicine. 2023;27(9):1157-1167. doi:10.1111/jcmm.17725

BibTeX
@article{Asrih2023,
  author = {Asrih, Mohamed and Wei, Shibo and Nguyen, Thanh T and Yi, Hyon-Seung and Ryu, Dongryeol and Gariani, Karim},
  title = {Overview of growth differentiation factor 15 in metabolic syndrome},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  volume = {27},
  number = {9},
  pages = {1157--1167},
  doi = {10.1111/jcmm.17725}
}
Kostenlos starten →